Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Bauza, M
- Aranda, EM
- Valls, AR
Grupos
Abstract
INTRODUCTION: This report presents uterine smooth muscle tumors of uncertain malignant potential course with an unpredictable clinical behavior and late metastases. Metastases have been described to the humerus, lung. and peritoneum. CASE PRESENTATION: Hereby we present the case of a 71-year-old woman with a past surgical history of hysterectomy and bilateral adnexectomy due to a smooth muscle tumor of unknown malignant potential, who was evaluated 6 years later after the appearance of a mass in the proximal third of the right lower limb. The mass was diagnosed as a G1 epithelioid leiomyosarcoma and was surgically removed with immediate reconstruction with a tendinous transfer to the tibialis posterior muscle to maintain foot dorsiflexion. CONCLUSION: Patients diagnosed with smooth uterine muscle tumors of uncertain malignant potential should be closely followed up given the possibility of recurrence and late metastases, bearing in mind uncommon locations as well. such as the lower limb.
Datos de la publicación
- ISSN/ISSNe:
- 1179-5476,
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 31258342
- Factor de Impacto:
- 0,198 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
CLINICAL MEDICINE INSIGHTS-CASE REPORTS Libertas Academica Ltd.
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- smooth muscle tumors of unknown malignant potential; leiomyosarcoma; metastases; lower extremity
Proyectos y Estudios Clínicos
RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010
INNOVATIVE APPROACH FOR SELF-MANAGEMENT AND SOCIAL WELFARE OF CYSTIC FIBROSIS PATIENTS IN EUROPE: DEVELOPMENT, VALIDATION AND IMPLEMENTATION OF A TELEMATICS TOOL. MyCyFAPP
Investigador Principal: CARMEN RIBES KONINCKX
643806_H2020-PHC-2014-single-stage-MyCyFApp . COMISION EUROPEA . 2015
MDS-RIGHT, PROVIDING THE RIGHT CARE TO THE RIGHT PATIENT WITH MYELODYSPLASTIC SYNDROME AT THE RIGHT TIME.
Investigador Principal: GUILLERMO SANZ SANTILLANA
634789 . COMISION EUROPEA . 2015
WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.
Investigador Principal: VICENTE PONS BELTRÁN
675353 . COMISION EUROPEA . 2016
COBIOPHAD. COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS.
Investigador Principal: MARÍA DOLORES HERNANDEZ FERNANDEZ DE ROJAS
688448 . COMISION EUROPEA . 2016
CROWDHEALTH: COLLECTIVE WISDOM DRIVING PUBLIC HEALTH POLICIES.
Investigador Principal: BERNARDO VALDIVIESO MARTÍNEZ
727560_VALDIVIESO_SC1 . INSTITUTO GRIFOLS SA; COMISION EUROPEA . 2017
IMMUNOMETABOLOMICS. CD8+ T cell metabolism in anti-tumor response.
Investigador Principal: AGUSTÍN LAHOZ RODRÍGUEZ
751423 . COMISION EUROPEA . 2017
OACTIVE. ADVANCED PERSONALISED, MULTI-SCALE COMPUTER MODELS PREVENTING OSTEOARTHRITIS. MODELOS COMPUTACIONALES MULTIESCALA, PERSONALIZADOS Y AVANZADOS PARA LA PREVENCIÓN DE LA ARTROSIS.
Investigador Principal: ENRIQUE VIOSCA HERRERO
777159_VIOSCA_SC1 . COMISION EUROPEA . 2017
Plataforma de Innovación en Tecnologías Médicas y Sanitarias - ITEMAS
Investigador Principal: SILVIA SÁNCHEZ SALVO
PT17/0005/0011 . INSTITUTO DE SALUD CARLOS III . 2018
Cita
GARCIA JM,Bauza M,PÉREZ A,Aranda EM,Valls AR. Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential. Clin Med Insights Case Rep. 2019. 12. UNSP 1179547619857680.